Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-088233
Filing Date
2024-07-31
Accepted
2024-07-31 07:05:26
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-20240630.htm   iXBRL 10-Q 2207014
2 EX-31.1 amrn-ex31_1.htm EX-31.1 11534
3 EX-31.2 amrn-ex31_2.htm EX-31.2 11989
4 EX-32.1 amrn-ex32_1.htm EX-32.1 11627
5 GRAPHIC img153235624_0.jpg GRAPHIC 144526
  Complete submission text file 0000950170-24-088233.txt   9536142

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20240630.xsd EX-101.SCH 1261088
72 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20240630_htm.xml XML 1755746
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 241159853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)